Our findings demonstrated that upregulation or downregulation of BHLHE41 resulted in a reduction or rise in the phosphorylation level of PI3K and AKT, suggesting that BHLHE41 has a negative regulatory effect on the PI3K/AKT signaling pathway in bladder cancer. This evidence concerns the gene BHLHE41 and urinary bladder carcinoma.